Gotz V P, Russell W L, Lopez L M
Ther Drug Monit. 1983;5(1):103-7. doi: 10.1097/00007691-198303000-00010.
The predictive ability of the "condition correction factor" method of estimating total body theophylline clearance as proposed by Powell et al. was evaluated in 22 acutely ill hospitalized patients. Actual theophylline clearance was calculated while the patient was on a constant infusion of aminophylline with serum theophylline concentrations obtained at steady-state conditions. Independently, theophylline clearance was estimated for each patient using condition correction factors. The relationship between actual and estimated total body theophylline clearance was evaluated using multiple regression analysis and correlation testing. The data failed to demonstrate any significant positive correlation between actual and estimated theophylline clearance data. Because of this poor correlation, the use of one of the clearance estimation methods incorporating two serum theophylline concentrations obtained early in therapy is preferable, although less convenient. All estimates of clearance must be considered only as guides for individualization of therapy. Serum concentration monitoring and clinical response of the patient must be considered prior to adjustment of dosage.
鲍威尔等人提出的“条件校正因子”法估算氨茶碱总体清除率的预测能力,在22名急性病住院患者中进行了评估。在患者持续输注氨茶碱并在稳态条件下获取血清氨茶碱浓度时,计算实际的氨茶碱清除率。另外,使用条件校正因子对每位患者的氨茶碱清除率进行估算。通过多元回归分析和相关性检验评估实际与估算的氨茶碱总体清除率之间的关系。数据未能显示实际与估算的氨茶碱清除率数据之间存在任何显著的正相关。由于这种相关性较差,尽管不太方便,但使用在治疗早期获得的两个血清氨茶碱浓度的清除率估算方法之一更为可取。所有清除率估算仅应视为个体化治疗的指导。在调整剂量之前,必须考虑患者的血清浓度监测和临床反应。